Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals That Shaped 2025: Midyear Highlights No Photo Available

Yeji Jesse Lee

As 2025 hits its midyear point, Law360 Healthcare Authority asked attorneys for their top choices for influential deals that have help... (more story)

Texas Goes Big On New Healthcare Laws No Photo Available

Mark Payne

It may be mid-summer, but Texas lawmakers are sending doctors and lawyers back to school for a course on what constitutes a "medical e... (more story)

RFK Jr. Walks Back Wearables Message Amid Data Concerns No Photo Available

Yeji Jesse Lee

Amid pushback about mass data collection and privacy risks, U.S. Department of Health and Human Services Secretary Robert Kennedy Jr. ... (more story)